SCYNEXIS, Inc. (SCYX)
0.705
-0.03
(-4.12%)
USD |
NASDAQ |
May 29, 16:00
0.7575
+0.05
(+7.45%)
After-Hours: 20:00
SCYNEXIS EPS Diluted (Quarterly) : -0.418 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.30M |
| Total Expenses (Quarterly) | 21.30M |
| Enterprise Value | -1.275M |
| Earnings Yield | -63.42% |
| Normalized Earnings Yield | -59.23 |